Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Visual Acuity in the PKC-DRS2 Study
Go back to Resources
Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Visual Acuity in the PKC-DRS2 Study
Authors:
Location:
Go back to Resources